JENNIFER TAWA: Open Payments
NPI 1811246978 · BEDFORD, NH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,088 in 44 payments from 9 companies in 2025. Trend: 2023 $669 · 2024 $966 · 2025 $1,088
Food & beverage: $1,088
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $349 |
| ABBVIE INC. | 16 | $260 |
| Otsuka America Pharmaceutical, Inc. | 4 | $150 |
| Axsome Therapeutics, Inc. | 3 | $85 |
| Corium, LLC | 4 | $72 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $68 |
| Lundbeck LLC | 2 | $43 |
| Teva Pharmaceuticals USA, Inc. | 2 | $42 |
| Neurocrine BioSciences, Inc. | 1 | $18 |
Products named: CAPLYTA, VRAYLAR, REXULTI, Auvelity, Azstarys, TRINTELLIX, AUSTEDO XR, INGREZZA.
Industry payments across NH — which companies pay providers there.
